Novartis Pharm. Corp. v. Lopes, 179 L. Ed. 2d 473 (2011). · Go Syfert
Novartis Pharm. Corp. v. Lopes, 179 L. Ed. 2d 473 (2011). Cases Citing This Book View Copy Cite
11 citation events (11 in the last 25 years) across 8 distinct courts.
Strongest positive: State v. Jones (conn, 2015-12-22)
Top citers, strongest first. 1 distinct citer. How cited ↗
discussed Cited "see, e.g." State v. Jones
Conn. · 2015 · signal: see, e.g. · confidence low
See, e.g., Reedy v. Evanson, 615 F.3d 197 , 227–30 (3d Cir. 2010) (plaintiff agreed to have her blood tested ‘‘for the purpose of evaluating the extent of her injuries and risk of disease from a sexual assault, and for the purpose of gathering physical evidence to prosecute her assailant,’’ but police violated her fourth amendment rights by conducting additional drug testing for investigative purposes because that testing fell outside scope of her consent, and plaintiff ‘‘indisputably had a reasonable expectation of privacy in her blood when it was drawn, and she did nothing to f…
Retrieving the full opinion text from the archive…
Novartis Pharmaceuticals Corporation
v.
Simona M. Lopes
No. 10-460.
Supreme Court of the United States.
Feb 28, 2011.
179 L. Ed. 2d 473
Published

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.

Same case below, 611 F.3d 141.